Related Experiment Video
Updated: Aug 6, 2026
09:30
Quantitative Magnetic Resonance Imaging of Skeletal Muscle Disease
Published on: December 18, 2016
Idiopathic myositis: a rheumatological view
M R Ehrenstein1, M L Snaith, D A Isenberg
1Department of Rheumatology Research, University College, London, United Kingdom.
Annals of the Rheumatic Diseases
|January 1, 1992
Summary
Idiopathic myositis patients require long-term follow-up. While treatments reduce mortality, significant morbidity persists, highlighting the need for ongoing patient care and research into myositis management.
Area of Science:
- Rheumatology
- Neurology
- Immunology
Background:
- Idiopathic inflammatory myopathies (IIMs) encompass polymyositis, dermatomyositis, and overlap syndromes.
- Long-term outcomes and management challenges in IIMs require further investigation.
Purpose of the Study:
- To evaluate the long-term follow-up data of patients with idiopathic myositis.
- To assess treatment efficacy, mortality, and morbidity in a cohort of myositis patients.
Main Methods:
- Retrospective analysis of 25 patients with idiopathic myositis followed from 1980-1989.
- Clinical assessment including muscle strength, creatine kinase levels, electromyography, and muscle biopsy.
- Serological testing for anti-Jo-1 and 56 kDa antibodies, and HLA typing.
Main Results:
- Proximal muscle weakness was universal; elevated creatine kinase and abnormal electromyograms were common.
- Anti-Jo-1 antibodies were rarely detected, but 56 kDa antibodies were present in 12/17 patients.
- While mortality was low (3 deaths), substantial morbidity persisted despite prednisolone and azathioprine treatment.
Conclusions:
- Long-term follow-up is crucial for managing idiopathic myositis.
- Current treatment strategies have improved survival but have not eliminated significant disease-related morbidity.
- Further research is needed to address the persistent morbidity in myositis patients.
Related Concept Videos
01:20Myasthenia Gravis: Overview and Treatment
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
01:15Myasthenia Gravis: Diagnostic Tests
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
01:21Myocarditis I: Introduction
Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
01:27Myocarditis II: Clinical Features and Diagnostic Tests
Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
01:23Rheumatic Heart Disease I: Introduction
Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
01:22Myasthenia Gravis ll: Pathophysiology
The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...